The efficacy of Vitamin D3 on seizure attacks in the patients with drug-resistant epilepsy

Phase 3

• Conditions: drug-resistant epilepsy.; Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus; G40.211

• Registration Number: IRCT20130730014217N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

drug-resistant epilepsy to treatment
No other disease
Vitamin D3 deficiency
Adult population over 18 years.

Exclusion Criteria

Patient's unwillingness and conscious dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of seizures. Timepoint: At beginning and 1, 2 and 3 months after treatment, patients were visited and the number and duration of seizures occurred. Method of measurement: Blood test and evaluation of 25OH vitamin D.